TrialBritish journal of haematology2026

Prospective, multicentre phase II study to evaluate the clinical benefit of reduced-dose lenalidomide and dexamethasone based on frailty stratification in elderly, unfit patients with newly diagnosed multiple myeloma.

Sung-Hoon Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.